News

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Sarepta Therapeutics (NASDAQ:SRPT) and its peers.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb (NYSE:BMY) and the best and worst performers in the branded pharmaceuticals industry.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the content delivery industry, including Akamai (NASDAQ:AKAM) and its peers.

Scott Bessent said the private sector “has been in a recession.”

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and worst performers in the dental equipment & technology industry.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the building materials stocks, including Sherwin-Williams (NYSE:SHW) and its peers.

The round includes around $10 million of debt from BlackRock.